Navigation Links
Elsevier congratulates Royal Australian Chemical Institute's Athel Beckwith Lectureship winner
Date:8/5/2010

Neuchtel, August 5, 2010 Elsevier Properties SA is pleased to congratulate Dr. Scott Stewart on his winning the Royal Australian Chemical Institute's (RACI) 2010/11 Athel Beckwith Lectureship, sponsored by Reaxys.

The award is open to all RACI members who have been appointed to their first academic or industrial position within the past five years. As the award winner, Dr. Stewart will be given the opportunity to present a lecture in at least six Australian state capitals and/or major regional centers during the year of the lectureship. The Organic Division of RACI established the annual lectureship to provide funding for outstanding early career organic chemists to travel around Australia and present the results of their research work.

Dr. Stewart, from the University of Western Australia, completed a PhD at the Research School of Chemistry (ANU) on the enantioselective synthesis of two new anti-cancer agents Taxol and Phomopsidin. His research interests include the synthesis of biologically active natural products using palladium catalysed cross coupling reactions; domino transformations in synthetic chemistry; medicinal chemistry for the treatment of cancer and immune diseases; and intramolecular Heck reactions using new nickel and palladium catalysts.

David Evans PhD, Scientific Affairs Director at Elsevier Properties SA said, "This lectureship provides a unique opportunity for chemists in the early stages of their careers and we would like to congratulate Dr. Stewart for his achievement in winning this award. We are pleased that this award grants scientists the recognition they deserve."

Reaxys is a unique web-based chemistry database combining reaction and substance data in organic, organometallic, inorganic and physical chemistry with synthesis planning. Reaxys allows researchers to get the information they need in a single overview, from source publications carefully selected for their importance and relevance to re
'/>"/>

Contact: Tom Reller
T.Reller@elsevier.com
215-239-3508
Elsevier
Source:Eurekalert

Page: 1 2

Related biology news :

1. Elsevier partners with the Royal Netherlands Society for Agricultural Sciences
2. Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award
3. Finalists announced in the Elsevier Grand Challenge
4. Winners announced in the Elsevier Grand Challenge
5. Elsevier announces 2008 journal impact factor highlights
6. Elseviers BrainNavigator research tool to launch new features at Neuroscience 2009 show
7. Elsevier pilots new research tool Reflect in its premier life science journal Cell
8. Gold Standard/Elsevier offers timely, reliable drug pricing data, including average wholesale price
9. Elsevier and Peking University Health Science Center develop new China online CME service
10. Elsevier pilots PeerChoice in Chemical Physics Letters
11. Elsevier announces the winner of the Ahmed Zewail prize in molecular sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), a leading developer ... report financial results for the fourth quarter and fiscal ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-455-2260 (conference ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... -- The Gladstone Institutes will receive funds totaling $5.6 ... major funding initiative focusing on HIV eradication. The funds ... biomedical-research organization, to explore the molecular basis for HIV ... within cells waiting for an opportunity to reemerge when ...
... testing biofilter systems as a viable alternative to releasing ... technology could reduce the overall impact of old landfills ... issue of the International Journal of Environmental Engineering ... sites generates a slow trickle of the potent greenhouse ...
... a high prevalence of vitamin D insufficiency and deficiency ... D levels was not observed in patients in southern ... Arthritis Care & Research , a journal of the ... between disease activity and vitamin D level. ...
Cached Biology News:Gladstone to receive $5.6 million in federal funds to seek a cure for AIDS 2Gladstone to receive $5.6 million in federal funds to seek a cure for AIDS 3Biofilters reduce carbon footprint of old landfill sites 2Vitamin D insufficiency prevalent among psoriatic arthritis suffers 2
(Date:7/30/2015)... ... 31, 2015 , ... Ralco is honored to announce that it is the ... be held August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience ... agriculture impacts their daily lives. This unique exhibit also features a birthing center for ...
(Date:7/30/2015)... , July 30, 2015 ... by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, ... & Development, Preclinical, Clinical Trial), by End Users - ... Market is expected to reach USD 2,107.99 million by ... CAGR of 15.29%. Browse more than ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
(Date:7/29/2015)... 2015 Sanofi, a global ... second quarter of 2015. CEO Olivier Brandicourt ... performance in different businesses. Watch video ... Topics covered in the interview ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... Kristin Lucas, ClearTrial Senior Director of Clinical Services, will lead a ... Cash Flow and Accruals" at the CBI Forecasting & Budgeting conference. ... over clinical trial budgets and improve management of clinical trial cash ... ...
... of $0.44 -- increase of 110% from prior year , ... KNSY ), a leading medical technology company that provides ... today reported the results for its second quarter and first six ... , Record EPS of ...
... Calif., Jan. 28 NeuroFocus, the world leader in,the ... named,preeminent cognitive neuroscientist John Polich, Ph.D., as its Director ... company made this selection as it ramps up the ... the United Kingdom, France, Italy, Germany,Japan, Korea, India, and ...
Cached Biology Technology:ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference 2ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference 3Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 2Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 3Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 4Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 5Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 6Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 7Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 8Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 9Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 10Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 11Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 12Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 13Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 14Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 15Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 16Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 17Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 18NeuroFocus Names John Polich, World-Renowned Scientist in Brain Function and Cognition, to Head Global NeuroLab Operations 2NeuroFocus Names John Polich, World-Renowned Scientist in Brain Function and Cognition, to Head Global NeuroLab Operations 3
... Kit, 1 kit. Convenient way ... Conjugations are carried out under mild ... Dyes are packaged in premeasured amounts ... Category: Blotting & Labeling & Detection, ...
...
Recombinant Mouse IL-23, CF...
...
Biology Products: